Skip to main content

Table 1 Association of Clinical and Laboratory variables with 30-day mortality in patients with alcoholic hepatitis.

From: Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

Variable

 

Number of patients

30-day mortality, %

p Value

Age

<46.5

17

6

0.09

 

>46.5

17

35

 

Gender

Female

11

27

0.66

 

Male

23

17

 

Temperature

<99.4

27

19

0.61

 

>99.4

7

29

 

Abdominal Pain

Yes

13

23

1.00

 

No

21

19

 

Cirrhosis

Yes

19

32

0.1

 

No

15

7

 

Encephalopathy

Yes

11

45

0.02

 

No

23

9

 

Varices

Yes

11

27

0.66

 

No

23

17

 

Splenomegaly

Yes

9

33

0.35

 

No

25

16

 

Ascites

Yes

17

41

<0.01

 

No

17

0

 

Bilirubin (mg/dL)

<2

15

7

<0.01

 

2–5

10

10

 
 

5–8

1

0

 
 

>8

8

63

 

Albumin (g/dL)

<3

13

38

0.02

 

3–4

13

0

 
 

>4

1

0

 

Creatinine (mg/dL)

<1.5

27

15

0.13

 

>1.5

7

43

 

AST/ALT

<1.2

3

0

0.12

 

1.2–1.6

5

0

 
 

>1.6

17

27

 

INR

<1.5

20

5

0.01

 

1.5–2.5

12

42

 
 

>1.6

2

50

 

AST (U/L)

<100

9

0

0.15

 

>100

23

26

 

ALT (U/L)

<100

18

22

1.00

 

>100

7

14

 

WBC (× 109/L)

<10

24

13

0.07

 

>10

9

44

 

Hemoglobin (g/dL)

<10

10

20

1.00

 

>10

23

22

 

Platelet count (× 109/L)

<50

3

33

0.52

 

>50

30

20